Evidence map›Paper›PMID 36275891›Full record

ArticleOxidative medicine and cellular longevity2022

4-Carbomethoxyl-10-Epigyrosanoldie E Extracted from Cultured Soft Coral

Yun-Ying She, Jen-Jie Lin, Jui-Hsin Su, Ting-Shou Chang, Yu-Jen Wu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in Small Molecular Agents against Oral Cancer.Molecules (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yun-Ying SheDepartment of Otolaryngology-Head and Neck Surgery, Kaohsiung Veterans General Hospital, Taiwan.
Jen-Jie LinYu Jun Biotechnology Co., Ltd., Kaohsiung, Taiwan.
Jui-Hsin SuNational Museum of Marine Biology and Aquarium, Pingtung 94450, Taiwan.
Ting-Shou ChangDepartment of Otolaryngology-Head and Neck Surgery, Kaohsiung Veterans General Hospital, Taiwan.
Yu-Jen WuYu Jun Biotechnology Co., Ltd., Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0002-8816-4725
Kaohsiung Veterans General Hospital · TWYu Jun BiotechnologyNational Museum of Marine Biology and Aquarium · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral cancer is a malignant neoplasia that is more common in Asian than other regions, and men are at higher risk than women. Currently, clinical treatment for oral cancer consists of radiation therapy combined with chemotherapy. Therefore, it is important to find a drug that can inhibit the growth of cancer cells more effectively and safely. In this study, we examined the cytotoxicity of 4-carbomethoxyl-10-epigyrosanoldie E extracted from cultured soft coral

Indexed as

AnthozoaMouth NeoplasmsAnimalsApoptosisApoptosis Regulatory ProteinsAutophagybcl-2-Associated X ProteinBeclin-1Caspase 3Cytochromes cDiterpenesEndoplasmic Reticulum StressFemaleHumansMaleMitochondria4-carbomethoxyl-10-epigyrosanoldie EApoptosis Regulatory Proteinsbcl-2-Associated X ProteinBeclin-1Caspase 3Cytochromes cDiterpenesMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2Reactive Oxygen Species

Identifiers

PMID36275891
PMCPMC9584738
OpenAlexW4306153796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.